SCHEMBL8842984

SCHEMBL8842984

Cc1cc(OCCCc2ccc3c(c2)C(=O)N(C(C)CC(=O)OC(=O)C(F)(F)F)C(c2ccccc2)C(=O)N3C(C)C)nc(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7324700 0.93
SCHEMBL7331753 0.93 MDM2 (0.31)
SCHEMBL7324426 0.92
Trifluoroacetic Acid SCHEMBL8842983 0.92 RXRA (0.30)
SCHEMBL7324082 0.91 MDM2 (0.33)
SCHEMBL7358111 0.87 MDM2 (0.31)
Trifluoroacetic Acid SCHEMBL7324690 0.86 MDM2 (0.30)
SCHEMBL7328925 0.85 MDM2 (0.32)
SCHEMBL7321439 0.84
SCHEMBL7329548 0.84 MDM2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed